How Amazon Prime Could Reach 100 Million Members by 2018

How Amazon Prime Could Reach 100 Million Members by 2018

As an investor interested in Amazon.com (NASDAQ:AMZN) stock, you probably already know the importance of Prime to the company. It has been well documented that Prime members spend more on Amazon than non-members, and the company is doing just about everything it can to grow its Prime membership base. Morgan Stanley analyst Brian Nowak estimates → Read More

Is Hillary Clinton an Ally to Long-Term Investors?

Is Hillary Clinton an Ally to Long-Term Investors?

Democratic presidential nominee Hillary Clinton has pledged to encourage long-term investment as well as investment in job-creating small businesses, but is Clinton a friend to long-term investors? Here are the investor-specific proposals from Clinton’s campaign that could shed some light on the matter. Clinton’s big change for investors: Capital gains tax rates The biggest change → Read More

Delta's New Pilot Contract Offer Puts Southwest Airlines in a Bind

Delta's New Pilot Contract Offer Puts Southwest Airlines in a Bind

After four years of contentious bargaining, Southwest Airlines (NYSE:LUV) finally reached a tentative agreement (TA) with its pilot union for a new contract in late August. The deal calls for Southwest to increase pilot wage rates by nearly 30% between now and 2020. Two weeks ago, the union’s board voted 21-2 to send the proposed → Read More

Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System

Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System

No, your eyes (or wallet) aren’t deceiving you — the perception of pharmaceutical price-gouging has certainly become more commonplace over the past year. Last September, Martin Shkreli, the “Bad Boy of Pharma,” increased the price of a 62-year-old rare-disease drug known as Daraprim by more than 5,500% overnight for the explicit reasoning of generating more → Read More

Billy Bush: The other voice in the Donald Trump video

Billy Bush: The other voice in the Donald Trump video

Trump’s uncensored lewd comments about women from 2005 Is he really…? Yes. Billy Bush is a member of that Bush family. His father, Jonathan Bush, is a banker and GOP donor who is the brother of former President George H.W. Bush. That means Billy Bush is a cousin to former President George W. Bush, as → Read More

Is Big Lots a Good Value?

Is Big Lots a Good Value?

Big Lots (NYSE:BIG) exceeded profit expectations when they reported earnings at the end of August, but the stock is down since then anyway. Why are shares down, and does the pullback make for a good bargain? The year so far in review Retail sales at general merchandise stores have been suffering in 2016 as they → Read More

3 Proven Ways to Boost Your Retirement Income

3 Proven Ways to Boost Your Retirement Income

Spending your golden years on a fixed income can make it challenging to afford life’s necessities. That’s why many retirees keep looking for ways to boost their incomes; even modest gains can help to create much-needed wiggle room in one’s budget. With that in mind, here’s are three ways seniors can make their finances more secure. 1. → Read More

Las Vegas Casinos See Opportunity Off-Strip

Las Vegas Casinos See Opportunity Off-Strip

In Las Vegas, the Strip gets a vast majority of the attention from both the national media and investors. Names most people know like MGM Resorts (NYSE:MGM), Caesars Entertainment (NASDAQ:CZR), and Wynn Resorts are just a few of the large gaming operators in Las Vegas, but there’s big gaming world off the Las Vegas Strip. → Read More

Why Plug Power Popped 11% in September

Why Plug Power Popped 11% in September

What happened Trading flat for the first half of September, shares of Plug Power (NASDAQ:PLUG) jumped 12% following two announcements: the company’s CEO, Andy Marsh, will be a featured speaker at the Wuhan HOME Innovation Summit in China, and he will be meeting with the mayor of Wuhan. The stock rode the surge through the rest of the month, → Read More

Why Chemours' Great Month (Up 18%) Ain't So Great

Why Chemours' Great Month (Up 18%) Ain't So Great

On the last day of September, the stock of DuPont (NYSE:DD) spinoff Chemours (NYSE:CC) hit $16 a share, a high it hadn’t seen in more than a year. On the first day of September, it had closed at $13.47 a share for a monthly gain of 18.8%.  And that’s just the icing on the cake. Since the → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.